Based on your assumptions, I would think that the longer a company waits after the interim results then the higher the acquisition/partnership price (assuming continued positive results).
For example, Otsuka recently acquired a "phase 3 ready" company (Neurovance) for $250M. The price would have been more than double (much more) if the company presented positive phase 3 interim results.